Ainos Inc (AIMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ainos Inc stock (AIMD) is currently trading at $1.46. Ainos Inc PS ratio (Price-to-Sales) is 90.81. WallStSmart rates AIMD as Sell.
- AIMD PE ratio analysis and historical PE chart
- AIMD PS ratio (Price-to-Sales) history and trend
- AIMD intrinsic value — DCF, Graham Number, EPV models
- AIMD stock price prediction 2025 2026 2027 2028 2029 2030
- AIMD fair value vs current price
- AIMD insider transactions and insider buying
- Is AIMD undervalued or overvalued?
- Ainos Inc financial analysis — revenue, earnings, cash flow
- AIMD Piotroski F-Score and Altman Z-Score
- AIMD analyst price target and Smart Rating
Ainos Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Ainos Inc (AIMD) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/book, revenue growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Ainos Inc (AIMD) Key Strengths (3)
Growing significantly faster than its price suggests
Revenue surging 412.40% year-over-year
Trading at 1.01x book value, attractively priced
Supporting Valuation Data
Ainos Inc (AIMD) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Very expensive at 90.8x annual revenue
Very low institutional interest at 0.64%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
Ainos Inc (AIMD) Detailed Analysis Report
Overall Assessment
This company scores 36/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 9.3/10) while 5 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Revenue Growth, Price/Book. Valuation metrics including PEG Ratio (0.93), Price/Book (1.01) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 412.40%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (90.81) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -97.80%, Operating Margin at -80328.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -97.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 412.40% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AIMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AIMD's Price-to-Sales ratio of 90.81x trades at a deep discount to its historical average of 331.04x (52th percentile). The current valuation is 98% below its historical high of 4051.02x set in Dec 2014, and 11111% above its historical low of 0.81x in Nov 2023. Over the past 12 months, the PS ratio has compressed from ~117.4x as trailing revenue scaled faster than the stock price.
Compare AIMD with Competitors
Top SCIENTIFIC & TECHNICAL INSTRUMENTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Ainos Inc (AIMD) · TECHNOLOGY › SCIENTIFIC & TECHNICAL INSTRUMENTS
The Big Picture
Ainos Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 110,870 with 412% growth year-over-year.
Key Findings
Revenue growing at 412% YoY, reaching 110,870. This pace significantly outperforms most SCIENTIFIC & TECHNICAL INSTRUMENTS peers.
Spending 1795% of revenue (2M) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -1M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Ainos Inc maintain 412%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 2.37, so expect amplified moves relative to the broader market.
Debt management: total debt of 11M is significantly higher than cash (1M). Monitor refinancing risk.
Sector dynamics: monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive moves, and regulatory changes that could impact Ainos Inc.
Bottom Line
Ainos Inc is a high-conviction growth story with revenue accelerating at 412% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Ainos Inc(AIMD)
NASDAQ
TECHNOLOGY
SCIENTIFIC & TECHNICAL INSTRUM...
USA
Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.